1. Home
  2. HHS vs XCUR Comparison

HHS vs XCUR Comparison

Compare HHS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HHS
  • XCUR
  • Stock Information
  • Founded
  • HHS 1923
  • XCUR 2011
  • Country
  • HHS United States
  • XCUR United States
  • Employees
  • HHS N/A
  • XCUR N/A
  • Industry
  • HHS Advertising
  • XCUR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HHS Consumer Discretionary
  • XCUR Health Care
  • Exchange
  • HHS Nasdaq
  • XCUR Nasdaq
  • Market Cap
  • HHS 26.9M
  • XCUR 32.4M
  • IPO Year
  • HHS N/A
  • XCUR N/A
  • Fundamental
  • Price
  • HHS $3.44
  • XCUR $5.10
  • Analyst Decision
  • HHS
  • XCUR
  • Analyst Count
  • HHS 0
  • XCUR 0
  • Target Price
  • HHS N/A
  • XCUR N/A
  • AVG Volume (30 Days)
  • HHS 12.9K
  • XCUR 37.0K
  • Earning Date
  • HHS 11-13-2025
  • XCUR 11-13-2025
  • Dividend Yield
  • HHS N/A
  • XCUR N/A
  • EPS Growth
  • HHS N/A
  • XCUR N/A
  • EPS
  • HHS N/A
  • XCUR N/A
  • Revenue
  • HHS $174,951,000.00
  • XCUR N/A
  • Revenue This Year
  • HHS $6.54
  • XCUR N/A
  • Revenue Next Year
  • HHS N/A
  • XCUR N/A
  • P/E Ratio
  • HHS N/A
  • XCUR N/A
  • Revenue Growth
  • HHS N/A
  • XCUR N/A
  • 52 Week Low
  • HHS $3.06
  • XCUR $2.15
  • 52 Week High
  • HHS $7.46
  • XCUR $36.00
  • Technical
  • Relative Strength Index (RSI)
  • HHS 41.95
  • XCUR 55.86
  • Support Level
  • HHS $3.55
  • XCUR $4.78
  • Resistance Level
  • HHS $3.73
  • XCUR $5.80
  • Average True Range (ATR)
  • HHS 0.05
  • XCUR 0.41
  • MACD
  • HHS -0.01
  • XCUR 0.21
  • Stochastic Oscillator
  • HHS 0.00
  • XCUR 65.70

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: